This mini review aims to outline some of the non testing approaches that are available for the purposes of predicting and assuring drug safety. Focus will be made on several endpoints of specific such as ADME properties as well as mutagenicity and carcinogenicity. The use of TTC and chemical categories approaches are presented as alternative strategies. Overall there is great potential to apply a battery of different tools in drug discovery from QSARs to TTC and chemical categories. Greater awareness of other initiatives (in parallel industries) coupled with more practical guidance on how to exploit these tools is still required before they become embedded into routine use.
TIER Grace;
2006-05-12
Bentham Science Publishers Ltd
JRC31693
https://publications.jrc.ec.europa.eu/repository/handle/JRC31693,
| Name | Country | City | Type |
|---|
This document is only visible at the Commission level.
You are not authorized to publish or distribute it outside the European Commission.
This is a public document. You can share this publication.
Datasets
| ID | Title | Public URL |
|---|
Dataset collections
| ID | Acronym | Title | Public URL |
|---|
Scripts / source codes
| Description | Public URL |
|---|
Additional supporting files
| File name | Description | File type |
|---|